Deal Activity

Snapshot of Centerview Partners in Biopharma M&A over 2023 and 2024

Posted on by

In this short post, I propose a quick snapshot of the M&A transactions Centerview have been involved in, during 2023 and 2024, to show by the data that the biopharma acquisitions are their forte. As the WSJ reported yesterday, the shareholders of Centerview Partners are exploring the sale of a stake in the boutique bank.[…]

Deal Monitor: status at the end of Q3 2019

Posted on by

It’s time to make a top view status of the deal activity for the 150+ European listed biotech companies in our universe. The data below include deals from all categories (R&D collaborations, Out-Licensing deals, Supply/Distribution deals, JV, IP licensing, Sales/Divestments), except the in-licensing deals. Please refer to our introductory report for more details and explanations.[…]